• Return to Headlines

Relatively Low Sales per Share Detected in Shares of Anthera Pharmace in the Biotechnology Industry (ANTH, CDTX, VTL, ZFGN, ACHN)

By Amy Schwartz

Below are the three companies in the Biotechnology industry with the lowest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.

Anthera Pharmace ranks lowest with a sales per share of $0.00. Cidara Therapeut is next with a sales per share of $0.00. Vital Therapies ranks third lowest with a sales per share of $0.00.

Zafgen Inc follows with a sales per share of $0.00, and Achillion Pharma rounds out the bottom five with a sales per share of $0.00.

SmarTrend is monitoring the recent change of momentum in Vital Therapies. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Vital Therapies in search of a potential trend change.

Keywords: lowest sales per share anthera pharmace cidara therapeut vital therapies zafgen inc achillion pharma

Ticker(s): ANTH CDTX VTL ZFGN ACHN